- Record: found
- Abstract: not found
- Article: not found
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
John Neoptolemos, Daniel H Palmer, Paula Ghaneh, Eftychia Psarelli, Juan W. Valle, Christopher Halloran, Olusola Faluyi, Derek O'Reilly, David Cunningham, Jonathan Wadsley, Suzanne Darby, Tim Meyer, Roopinder Gillmore, Alan Anthoney, Pehr Lind, Bengt Glimelius, Stephen Falk, Jakob Izbicki, Gary Middleton, Sebastian Cummins, Paul J Ross, Harpreet S Wasan, Alec McDonald, Tom Crosby, Yuk Ting Ma, Kinnari Patel, David Sherriff, Rubin Soomal, David Borg, Sharmila Sothi, Pascal Hammel, Thilo Hackert, Richard Jackson, Markus W. Büchler
2017-03-01
Read this article at
ScienceOpenPublisher
- open (via crossref license)
- oa repository (via OAI-PMH doi match)
- oa repository (via OAI-PMH doi match)
- oa repository (via OAI-PMH doi match)
- oa repository (via OAI-PMH doi match)
- oa repository (via OAI-PMH title and first author match)
- oa repository (via OAI-PMH doi match)
- oa repository (via OAI-PMH doi match)
- oa repository (via OAI-PMH doi match)
Powered by 
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.